50 Best Performing Stocks Year to Date

Jun. 27, 2011 4:15 PM ETAMPE, BIOL, CASC, GLBC, GMCR, WW, MSTR, SNBR, NSM, TBL1 Comment
Bespoke Investment Group profile picture
Bespoke Investment Group
45.64K Followers

As we quickly approach the halfway point of 2011, below is a list of the 50 best performing stocks in the Russell 3,000 year to date. Technology stocks typically dominate this list, but at this point in the year, only one Technology stock ranks in the top ten (TeleNav in 10th place). Three Health Care stocks sit at the top of the list. Ampio Pharmaceuticals (AMPE) is currently the best performing Russell 3,000 stock year to date with a gain of 227%. Biolase Technology (BLTI) ranks second with a gain of 201.37%, followed by Oncothyreon (ONTY) at 182.70%. Global Crossing (GLBC) -- a Telecom company -- is the 4th best performing stock year to date with a gain of 174.54%, while Green Mountain Coffee (GMCR) ranks fifth with a gain of 158.67%. Other notables on the list of 2011 winners include Weight Watchers (WTW), MicroStrategy (MSTR), Select Comfort (SCSS), National Semiconductor (NSM), and Timberland (TBL).

This article was written by

Bespoke Investment Group profile picture
45.64K Followers
Bespoke Investment Group provides some of the most original content and intuitive thinking on the Street. Founded by Paul Hickey and Justin Walters, formerly of Birinyi Associates and creators of the acclaimed TickerSense blog, Bespoke offers multiple products that allow anyone, from institutions to the most modest investor, to gain the data and knowledge necessary to make intelligent and profitable investment decisions. Along with running their Think B.I.G. finance blog, Bespoke provides timely investment ideas through its Bespoke Premium (http://bespokepremium.com/) subscription service and also manages money (http://bespokepremium.com/mm) for high net worth individuals. Visit: Bespoke Investment Group (http://bespokeinvest.com/)

Recommended For You

Comments (1)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.